"Advanced melanoma" trang 1 - tải miễn phí từ tailieunhanh
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study
10    26    1
Comparative efficacy and safety of combination therapies for advanced melanoma: A network meta-analysis

Comparative efficacy and safety of combination therapies for advanced melanoma: A network meta-analysis
10    49    1
Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: A model-based economic evaluation

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: A model-based economic evaluation
11    72    1
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: The IMAGE study

Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: The IMAGE study
12    64    1
Báo cáo hóa học:

Báo cáo hóa học: "Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma"
11    38    0
Vemurafenib in Chinese patients with BRAFV600 mutation–positive unresectable or metastatic melanoma: An open-label, multicenter phase I study

Vemurafenib in Chinese patients with BRAFV600 mutation–positive unresectable or metastatic melanoma: An open-label, multicenter phase I study
7    60    1
A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma

A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma
9    27    1
Total serum N‑glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma

Total serum N‑glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
12    6    1
Ebook Dermatology for advanced practice clinicians (1st edition): Part 1

Ebook Dermatology for advanced practice clinicians (1st edition): Part 1
188    88    0
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial
9    42    1
ADAS for the Car of the Future - Interface Concepts for Advanced Driver Assistant Systems in a Sustainable Mobility Concept of 2020

ADAS for the Car of the Future - Interface Concepts for Advanced Driver Assistant Systems in a Sustainable Mobility Concept of 2020
68    55    0
Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: Pooled analysis of clinical trials

Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: Pooled analysis of clinical trials
6    45    0
Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: Potential role of Th1-dominant immune response in immune-related adverse events: Two case reports

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: Potential role of Th1-dominant immune response in immune-related adverse events: Two case reports
7    55    0
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma

Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
7    37    1
Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
14    74    1
Association of advanced age and cancer history with autoimmune disease in melanoma patients: A cross-sectional study

Association of advanced age and cancer history with autoimmune disease in melanoma patients: A cross-sectional study
8    55    3
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: A single-arm, multicenter, phase II study

Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: A single-arm, multicenter, phase II study
11    4    1